Status:
UNKNOWN
Neurodegenerative Diseases Registry
Lead Sponsor:
Vincent Mok
Conditions:
Neurodegenerative Diseases
Parkinson Disease
Eligibility:
All Genders
18-80 years
Brief Summary
With the increase in life expectancy of our population due to advancement of medical diagnosis and treatments, the incidence of age dependent neurodegenerative diseases increased, including Alzheimer'...
Detailed Description
This is a cohort study. It involves baseline, 1st follow up visit and 2nd follow up visit. At baseline visit, all participants will go through a list of assessments and questionnaires and blood taking...
Eligibility Criteria
Inclusion
- Age should be between 18-80 years old.
Exclusion
- Patients with ongoing central nervous system infection and/or acute stroke or active brain tumor.
Key Trial Info
Start Date :
October 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT04472130
Start Date
October 9 2019
End Date
August 1 2024
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese University of Hong Kong
Hong Kong, Hong Kong